The abstract is read at the publisher; the summary is JClub's.
In the Type 1 Diabetes Genetics Consortium cohort, 7.6% of autoantibody-negative young-onset type 1 diabetes cases are estimated to be nonautoimmune based on genetic risk score patterns.
- Why it matters: Autoantibody-negative type 1 diabetes (10–15% of cases) has an unknown etiology, creating diagnostic uncertainty with potential treatment consequences.
- What they did: Using 2,500 affected sibling pairs, the study compared Type 1 Diabetes Genetic Risk Score (GRS2) in 379 autoantibody-negative patients with an autoantibody-positive sibling versus 253 autoantibody-negative patients with no autoantibody-positive siblings.
- The result: The unknown-cause group showed a distinct minor mode (1.2%) and a higher frequency of GRS2 scores <9.83, yielding a maximum-likelihood nonautoimmune proportion of 7.6%.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.